e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Respiratory infection caused by Pseudomonas aeruginosa
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia trough enterobacteriaceae and
p. aeruginosa
: diagnosis, incidence, and predictors. The German CAPNETZ
H. von Baum, T. Welte, R. Marre, N. Suttorp, E. Santiago (Ulm, Hannover, Berlin, Bochum, Germany)
Source:
Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Session:
Respiratory infection caused by Pseudomonas aeruginosa
Session type:
Oral Presentation
Number:
1360
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. von Baum, T. Welte, R. Marre, N. Suttorp, E. Santiago (Ulm, Hannover, Berlin, Bochum, Germany). Community-acquired pneumonia trough enterobacteriaceae and
p. aeruginosa
: diagnosis, incidence, and predictors. The German CAPNETZ. Eur Respir J 2009; 34: Suppl. 53, 1360
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Community-acquired pneumonia in outpatients: aetiology and outcomes},
Source: Eur Respir J 2012; 40: 931-938
Year: 2012
Community-acquired pneumonia in the elderly
Source: Eur Respir Mon; 2009: 43: 111–132
Year: 2009
Community-acquired pneumonia in younger patients is an entity on its own
Source: Eur Respir J 2012; 39: 1156-1161
Year: 2012
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
PATS and ERS paediatric webinar: reducing the burden of CAP
Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP
Year: 2021
Community-acquired pneumonia
Source: Respipedia Article
Year: 2017
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Source: Eur Respir J 2008; 32: 139-146
Year: 2008
Community-acquired pneumonia in the elderly: Spanish multicentre study
Source: Eur Respir J 2003; 21: 294-302
Year: 2003
Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Community-acquired pneumonia (CAP) and pregnancy
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Community-acquired pneumonia in the elderly, about 50 cases
Source: Eur Respir J 2006; 28: Suppl. 50, 376s
Year: 2006
Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Community-acquired paediatric pneumonia (CAPP). Is antibiotic treatment universally required?
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept